Showing 291-300 of 468 results for "".
- FDA Clears New Indication for UltraClear Laserhttps://modernaesthetics.com/news/fda-clears-new-indication-for-ultraclear-laser/2473577/The U.S. Food and Drug Administration (FDA) cleared a new indication of Acclaro Medical's UltraClear® cold ablative fractional 2910 nm fiber laser, expanding the use of the technology for the treatment of benign pigmented lesions and vascular dyschromia, the company announced i
- Glamour Ranks Best Face Moisturizershttps://modernaesthetics.com/news/glamour-ranks-best-face-moisturizers/2473574/Glamour released its “22 Best Face Moisturizers” list, naming SkinMedica’s HA5 Rejuvenating Hydrator the best overall. “I think my skin actually looks different—in a good way,” one tester said of the SkinMedica product. The monthslong process
- Aesthetic Society Names New Presidenthttps://modernaesthetics.com/news/aesthetic-society-names-new-president/2473569/The Aesthetic Society announced the appointment of Kiya Movassaghi, MD, DMD, FACS, a board-certified plastic surgeon from Eugene, Oregon, as its president, saying his leadership will focus on strategically fortifying The Society's position as the global leader in education and innov
- BIOCORNEUM Joins Bioderma Portfoliohttps://modernaesthetics.com/news/biocorneum-joins-bioderma-portfolio/2473567/Nuance Medical announced the successful acquisition of BIOCORNEUM, a silicone gel scar treatment brand previously owned by Sientra, according to a press release. Effective immediately, BIOCORNEUM will become a part of the Biodermis portfolio, Nuance Medical’s brand specializing in silicone
- Murad Alam, MD, FAAD, Elected American Academy of Dermatology President for 2026https://modernaesthetics.com/news/murad-alam-md-faad-elected-american-academy-of-dermatology-president-for-2026/2473558/Chicago-based board-certified dermatologist Murad Alam, MD, FAAD, has been elected to lead the American Academy of Dermatology (AAD). He will be installed as president-elect in March 2025 and hold the office of president for 1 year beginning in March 2026. AAD is the world’s large
- Letybo (letibotulinumtoxinA-wlbg) Receives FDA Approvalhttps://modernaesthetics.com/news/fda-grants-approval-for-letybo-letibotulinumtoxina-wlbg/2473551/Hugel America, Inc., announced the achievement of a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for its neurotoxin, Letybo. "We are thrilled with the FDA's approval of Letybo. This is a huge achievement for Hugel as we
- HH Science Receives Brand's 1st U.S. Patent for Balanced Skin Clear Skin Vitaminshttps://modernaesthetics.com/news/hh-science-receives-brands-1st-us-patent-for-balanced-skin-clear-skin-vitamins/2473545/HH Science has received the brand's 1st patent for their Balanced Ski Clear Skin Vitamins. The U.S. Patent and Trademark Office has issued patent No. 11,877,998 which will be officially released on January 23, 2024.
- Eucerin Introduces First Face Care Collection With Multi-Weight Hyaluronic Acid Technologyhttps://modernaesthetics.com/news/eucerin-introduces-first-face-care-collection-with-multi-weight-hyaluronic-acid-technology/2473544/Hitting shelves January 2024, Eucerin's Immersive Hydration Collection is a new entry into the face-care category with a unique, multi-weight hyaluronic acid formulation. A first to pioneer this technology across a full face care regimen* to intensively hydrate skin and visibly smoo
- Industry Vet Matthew Hill Named CFO at Apyx Medical Corporationhttps://modernaesthetics.com/news/industry-vet-matthew-hill-named-cfo-at-apyx-medical-corporation/2473534/Matthew Hill is Apyx Medical Corporation’s (new Chief Financial Officer (CFO), effective December 4, 2023. Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023. “With its innovative Renuvion technology, large, global m
- Amogh Kothare Is Advalight’s New Chief Scientific Officerhttps://modernaesthetics.com/news/amogh-kothare-is-advalights-new-chief-scientific-officer/2473532/Amogh Kothare is the new Chief Scientific Officer of Advalight. In this role, Mr. Kothare will be responsible for clinical research, partnerships, product management, and clinical affairs and training to further leverage the brand. A "Under Amogh's sci